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ABSTRACT: Electrostatic effects are ubiquitous in protein
interactions and are found to be pervasive in the complement
system as well. The interaction between complement fragment
C3d and complement receptor 2 (CR2) has evolved to
become a link between innate and adaptive immunity.
Electrostatic interactions have been suggested to be the
driving factor for the association of the C3d:CR2 complex. In
this study, we investigate the effects of ionic strength and
mutagenesis on the association of C3d:CR2 through Brownian
dynamics simulations. We demonstrate that the formation of
the C3d:CR2 complex is ionic strength-dependent, suggesting
the presence of long-range electrostatic steering that
accelerates the complex formation. Electrostatic steering occurs through the interaction of an acidic surface patch in C3d and
the positively charged CR2 and is supported by the effects of mutations within the acidic patch of C3d that slow or diminish
association. Our data are in agreement with previous experimental mutagenesis and binding studies and computational studies.
Although the C3d acidic patch may be locally destabilizing because of unfavorable Coulombic interactions of like charges, it
contributes to the acceleration of association. Therefore, acceleration of function through electrostatic steering takes precedence
to stability. The site of interaction between C3d and CR2 has been the target for delivery of CR2-bound nanoparticle, antibody,
and small molecule biomarkers, as well as potential therapeutics. A detailed knowledge of the physicochemical basis of C3d:CR2
association may be necessary to accelerate biomarker and drug discovery efforts.
■ INTRODUCTION
Electrostatics plays an important role in accelerating bio-
molecular reactions, such as diffusional encounters and catalytic
processes.1−5 Both long-range and short-range electrostatic
interactions have been shown to affect the protein−protein
association rate6−8 and have demonstrated important con-
tributions to improving the efficiency of enzymatic reactions,
often by several orders of magnitude.9,10 An area of research
that has received significant attention in recent computational
studies is the role of electrostatics in the function and
regulation of the complement system, as well as the
electrostatic mechanisms that bacterial and viral proteins have
evolved to infiltrate host cells or evade the immune
system.11−20
The complement system is a vital component of innate
immunity, acting as a rapid-response surveillance system that
identifies and eliminates, or contributes to the elimination of
foreign pathogens through the processes of inflammation,
opsonization, phagocytosis, and direct cell lysis.21 In addition,
the complement system contributes to clearance of apoptotic
cells, damaged cells and cellular debris, and immune
complexes.22−26 The complement system is tightly regulated
to discriminate self-from nonself,27 and when such regulation
fails, the complement system contributes to autoimmune and
inflammatory diseases.28−30 Overall, the complement system
senses and responds to danger signals, contributing to host
homeostasis.23,25
A direct result of complement activation is the role it plays as
a link between innate and adaptive immunity, through the
interaction between complement fragment C3d and comple-
ment receptor 2 (CR2). This is a property of mammals and
higher species, because invertebrates have complement immune
response but lack adaptive immunity. The formation of the
C3d:CR2 complex contributes to the formation of the B cell
receptor−coreceptor complex and to the enhancement of B
cell-mediated antibody production by up to 3−4 orders of
magnitude.31−33 Due to the importance of the C3d:CR2
complex to the development of autoantibodies, the C3d:CR2
interaction is also implicated in the pathology of autoimmune
and inflammatory diseases. Thus, a comprehensive under-
standing of the nature of the C3d:CR2 interaction not only will
contribute to mechanistic knowledge of a fundamental immune
response process, but also can serve as the basis for
improvements in therapeutic development.
Complement activation occurs through three different
pathways: the classical, alternative, and lectin pathways. All
three pathways converge at complement component C3.34
Complement C3 undergoes a series of cleavage steps that
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activate, inactivate, and redirect its activation. The first cleavage
step produces the opsonin fragment C3b that covalently
(through a thioester bond) attaches to pathogens and other
surfaces, tagging them for recognition and elimination by
phagocytic cells, and the fragment C3a that contributes to
inflammatory response and phagocytosis. The second cleavage
step produces the so-called inactivated C3b, iC3b, which also
contributes to phagocytosis. The final cleavage steps produce
C3c and C3dg, which is immediately transformed to C3d.
Although C3d is the final cleavage product that remains on cell
surfaces for the life of the cell, it is not just a degradation
product. Nature has evolved mechanisms that utilize antigen-
bound C3d and B cell expressed CR2 as a site of interaction
between innate and adaptive immunity. B cell expressed
antibodies also opsonize pathogens by binding to antigens on
pathogen surfaces. Thus, the combined function of B cell
bound antibodies and the CR2-C3d complex cross-link B cells
to pathogens, forming the so-called B cell receptor (antibody)−
coreceptor (CR2) complex. This cross-linking initiates a
cascade of intracellular signaling reactions, involving protein
kinases.
Several structural and computational studies have proposed
that the interaction between C3d and CR2 is predominantly
electrostatic in nature,35−39 occurring through a negatively
charged patch on a concave surface of C3d and the first two
modules of CR2 that are positively charged (Figure 1).
Experimental studies involving mutagenesis, pH, and ionic
strength effects are in agreement with the dominant role of
electrostatics in the association between C3d and
CR2.35,36,40−42 Although there was ambiguity and controversy
for several years because of an older nonphysiological
crystallographic structure of the C3d:CR2 complex, this
controversy is now resolved with new crystallographic,
mutagenesis and binding, and computational data.19,36,41,43 A
recent study has evaluated the physicochemical origins and
strength of the C3d:CR2 interaction, using the physiological
and the controversial crystallographic structures, and has
demonstrated the electrostatic mechanism of binding.19 This
and earlier studies37−39 have proposed a two-step model for
C3d:CR2 association, consisting of recognition and binding for
highly and oppositely charged proteins. This model was based
on earlier work on electrostatic steering in enzymatic reactions
and protein interactions by McCammon and co-work-
ers.1−10,44−46 During the recognition step, long-range electro-
static interactions between protein macrodipoles accelerate the
formation of a transient encounter complex, followed by the
binding step, which is marked by the stabilization of the bound
complex through short-range, pairwise polar and nonpolar
interactions and entropic effects.
Another recent study used the concept of “electrostatic
hotspots” to evaluate the origin of the C3d−CR2 interaction
throughout evolution.47 An “electrostatic hotspot” was defined
as a surface patch of like-charged residues that is resistant to
perturbation. Such hotspots contribute to the formation of the
encounter complex and rapid association. Because of the high
concentration of like charges, a hotspot forms an unfavorable
electrostatic environment, which is amenable to the formation
of favorable interactions with proteins that have areas with
complementary charges when such an encounter occurs. The
study was performed using C3d sequences from 24 species,
homology modeling based on the most recent (physiological)
crystallographic structure, perturbations based on alanine scan
of ionizable residues and molecular dynamics simulations,
Poisson−Boltzmann electrostatic calculations, and electrostatic
potential similarity clustering. The study proposed that C3d has
two “electrostatic hotspots” located at opposite faces; one
hotspot is predominantly positively charged and contains the
thioester bond that opsonizes pathogen surfaces, and the other
hotspot is predominantly negatively charged and forms the
concave surface that is the site of interaction with CR2. The
study concluded that the appearance of the negatively charged
hotspot coincides with the onset of adaptive immunity at the
level of jawless fish and beyond, and it is stronger in mammals,
but it is not present in invertebrates. Therefore, C3d evolved its
electrostatic properties to acquire the negatively charged
hotspot to interact with the positively charged CR2, resulting
to enhancement of adaptive immunity.
Given the large number of background studies on the
electrostatic character of the C3d-CR2 interaction, and that the
formation of the encounter complex is a diffusion-limited
process,48 we initiated a Brownian dynamics (BD) simulation
study to evaluate kon reaction rate constants for C3d:CR2
complexes. We perform our study for native C3d and CR2, as
well as for a number of mutants with available experimental
binding data. We evaluate the ionic strength dependence of the
C3d:CR2 interaction to investigate the impact of salt
concentration on electrostatic screening. We utilize computa-
tional mutagenesis to elucidate the contributions of specific
mutants, with known experimental binding data, to the
association of the C3d:CR2 complex. We demonstrate the
inverse relationship between the association rate constant and
ionic strength.We also find that mutations of residues shown to
enhance or hinder binding in experimental binding data35,40,41
result in slower or higher association rate constants,
respectively. The examined mutations involved ionizable
residues at the binding interface and were introduced to
disrupt association. Our results are in agreement with the
experimental data, as well as with a previous computational
study,19 and they indicate that the electrostatic steering
accelerates the interaction between C3d and CR2.
■ METHODS
Protein Structure Preparation. We utilized the more
recent crystallographic structure of the C3d:CR2 complex
(Protein Data Bank, PDB, code: 3OED)36 in our study. From
the three-dimensional coordinates of this structure, we used
chains A and C, corresponding to C3d and CR2, respectively,
as they had better electron density and lower B-factor
Figure 1. Electrostatic potentials mapped onto the protein surfaces of
C3d and CR2 in open book representation. Electrostatic potentials
were calculated at ionic strength corresponding to 150 mM
monovalent counterion concentration. The color transitions from
red to white to blue represent electrostatic potential values of −5 kT/e
to 0 kT/e to 5 kT/e.
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compared to chains B and D of another complex present in the
structure. It should be noted that the structure of CR2 contains
only the two modules that contact C3d, SCR1, and SCR2, out
of a total of 15 or 16 SCR modules. C3d consists of 292 amino
acids with a net charge of −1e while CR2 consists of 130 amino
acids with a net charge of +8e. To alleviate crystal packing
effects in the crystallographic structure, 25 000 steps of
conjugate-gradient energy minimization were performed using
NAMD.49
Subsequent to energy minimization, missing hydrogens,
atomic radii, and partial charges were added to the coordinates
of the structure, using PDB2PQR version 2.050 and the PARSE
force field,51 thus converting the PDB file to a PQR file. No
atypical protonation states were observed using PROPKA.52,53
Histidine residues were neutral with a hydrogen attached to Nδ1
atom. Computational mutagenesis was performed on the
protein complex using the analysis of electrostatic similarities
of proteins (AESOP) computational framework.15,39,54,55
Mutants were chosen from prior literature that had reported
experimental binding data.35,40,41 Electrostatic potentials were
calculated for the parent (wild-type) and mutated protein
complexes using the Adaptive Poisson−Boltzmann Solver
(APBS) version 1.4.56 The number of grid points was set to
129 × 161 × 161. Coarse and fine mesh dimensions were set to
1000 Å × 1000 Å × 1000 and 150 Å × 150 Å × 150 Å,
respectively, as discussed previously.54 Protein and solvent
dielectric values were set to 20 and 78.54, respectively.54 Ionic
strengths corresponding to monovalent counterion concen-
trations of 50, 75, 100, 125, 150, 200, and 300 mM were used
for the evaluation of ionic strength dependence of parent
C3d:CR2 and the alanine scan mutants. An ionic concentration
of 150 mM was used in the electrostatic analysis of the alanine
scan mutants.
Brownian Dynamics Simulations. Brownian dynamics
simulations and the corresponding rate calculations were
performed using the BrownDye package,57 according to the
Northrup−Allison−McCammon algorithm,44 which is based
on the original Brownian dynamics algorithm by Ermak and
McCammon.58 The two molecules start separated at a center-
to-center radius (represented by the inner circle in Figure 2A),
and the simulation progresses until termination due to
formation of the encounter complex or due to the molecule
reaching an escape radius (represented by the outer circle in
Figure 2A). The center-to-center radius is calculated by
BrownDye for each system, and through an improvement to
the Northrup−Allison−McCammon algorithm, the escape
radius is no longer a necessary input.59 Pairwise residue
interactions with cutoff distances of 5.0 Å were calculated from
the PQR files generated as described above. Criteria for a
successful reaction required that at least two of the atom pairs
from the calculated list of pairwise interactions approach within
3.495 Å of each other (Figure 2B).
Reaction criteria were selected to match known rate
constants of C3d:CR2 association. Initially, the BrownDye
program rates_of_distances was utilized to generate a list of
reaction constants corresponding to minimum reaction
distances. Then, the criteria were fine-tuned to the known
association rate constant at 125 mM NaCl from experimental
data.40 There are two experimental association rate constants, at
50 and 125 mM NaCl ionic strength, and we chose for
calibration the value at 125 mM because of its proximity to the
physiological ionic strength of 150 mM. Additional input files
were generated using the program bd_top. BD simulations
were carried out using the weighted-ensemble method to
account for low probabilities of reactions.60 The association rate
constant, kon, and corresponding reaction probabilities were
calculated using weighted-ensemble simulations carried out for
2 000 000 steps with 200 copies of each system to guarantee
convergence of the results. The acceleration of protein−protein
association, as well as enzymatic reactions, by electrostatic
steering has been explored previously, which suggested the
feasibility of this study.61,62
■ RESULTS AND DISCUSSION
Ionic Strength Dependence of Association. The
weighted-ensemble BD simulations of C3d:CR2 demonstrate
that under constraints of reaction criteria of 3.495 Å and at least
two successful pairwise interactions, the association rate
constant decreases with increasing ionic strength (Figure 3),
which is expected when ionic screening of Coulombic
interactions is present. The experimental data utilized for
calibration of the reaction criteria is plotted in Figure 3 as well.
Additionally, Figure 3 shows the ionic strength dependence of
the Debye length, suggesting the importance of ionic screening
Figure 2. Schematic and molecular graphics illustrating the Brownian dynamics (BD) simulation of C3d:CR2 and the corresponding reaction criteria
with C3d and CR2 in blue and red, respectively. (A) At the beginning of the BD simulation, CR2 starts at a center-to-center radius away from C3d,
as represented by the inner circle. The simulation terminates when either the formation of the encounter complex occurs or if CR2 reaches an escape
radius as represented by the outer circle. (B) The concentric circles represent the reaction criteria for the C3d:CR2 BD simulations where 5 Å is the
cutoff for determining potential pairwise residue interactions between C3d and CR2. The circle with radius 3.495 Å represents the distance within
which at least two atom pairs of the previously determined pairwise residue interactions must occur for a successful reaction.
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for association. Both the ionic strength dependence and Debye
length curves follow similar trends.
Because C3d and CR2 have surfaces that are both highly and
oppositely charged (Figure 1), we expect that association
follows the two-step model of recognition (formation of the
intermediate encounter complex) and binding (formation of
the final bound complex). This is demonstrated by the ionic
strength dependence of the association, which is possible if
electrostatics drives association. From our results, the
acceleration of the interaction through electrostatic steering
underscores the plausibility of the model. The kinetic rate
constants acquired through these BD simulations reflect the
recognition step, given the calculation limitation, such as the
rigid body assumption of the protein structures and lack of
modeling of short-range interactions such as salt bridges, van
der Waals forces, and hydrogen bonding.63 These limitations
may affect only the binding step of the aforementioned two-
step model of protein−protein association and may not be
necessary for the evaluation of electrostatic steering during the
diffusion-limited recognition step.64
Impact of Specific Residues on Electrostatic Steering.
We investigated the effects of electrostatic steering when
various C3d:CR2 residues are mutated. Computational
mutations were chosen from available experimental data and
BD simulations were performed for each mutant system. We
observe that mutations of certain residues result in a decrease in
the association rate constant, or in other words, the residue is
significant to the formation of the encounter complex of
C3d:CR2 (Figure 4A,B). The reverse holds true as well where
mutations of residues resulting in an increase in the association
rate constant signify that the residue hinders the formation of
the encounter complex. These results are in line with a previous
computational alanine scan and electrostatic analysis study
using AESOP19 with a few small discrepancies such as K251A
Figure 3. Association rate constant of CR2 binding to C3d and the
calculated Debye length at varying ionic strengths. The mean
association rate constant is represented by a green circle with 95%
confidence intervals represented as error bars. The Debye length at
each ionic strength is represented as a purple square. Experimentally
known association rate constants at two ionic strengths, 50 mM and
125 mM NaCl, are plotted and represented as orange triangles.40
Note: the experimental data point at 125 mM was utilized for
calibration of the BD simulation reaction criteria.
Figure 4. Effects of mutagenesis on association rate constant and ionic strength dependence. (A, B) The mean association rate at 150 mM ionic
strength is plotted for each mutant for C3d and CR2 with 95% confidence intervals represented as error bars. The shaded region represents the
upper and lower bound threshold of the association rate constant values of the parent (C3d or CR2). Computational mutations were performed
based on previous experimentally generated mutants.35,40,41 (C, D) Ionic strength dependence of selected mutants demonstrating significant
deviations from the wild type association rate constant. The mutant notation denotes the residue number surrounded by the replaced residue on the
left and the replacing residue on the right.
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on C3d and R83A on CR2, which are close to the threshold of
the error. Thus, we establish that the acceleration of the
formation of the encounter complex due to electrostatic
steering is affected by individual charged residues contributions
as well.
Mutants displaying significant variance from the wild-type
(outside the shaded area of Figure 4A,B) were selected for ionic
strength dependence analysis (Figure 4C,D). We find that the
mutants exhibit ionic strength dependence as well, and the
trends are overall in line with what we would expect from the
mutagenesis analysis of Figure 4A,B. As expected from the
mutagenesis analysis, certain mutants demonstrate more drastic
electrostatic steering, suggesting that they play a more
significant role in the formation of the encounter complex.
Comparison with Prior Experimental and Computa-
tional Studies. A recent computational study investigating the
binding mode of C3d:CR2 using molecular dynamics (MD)
simulations (both explicit-solvent and steered), including MM-
GBSA analysis, and electrostatic calculations, including AESOP
alanine scan analysis, quantifies why the acidic patch on C3d
plays a key role in driving the C3d:CR2 interaction.19 In
particular, two clusters of C3d residues (D36, E37, and E39;
E160, K162, D163, E166, and E167) demonstrate significant
contributions to electrostatic interactions, intermolecular
interaction occupancies (hydrogen bonds, salt bridges, and
nonpolar interactions) and steered MD (SMD) simulations.
The computational study also emphasizes the importance of
both the SCR1 and SCR2 domain to the stability and
energetics of the complex. This is supported by the electrostatic
and MD simulation analysis and also was strongly suggested by
the slow unbinding of the SCR1 domain in SMD simulations,
in contrast to the SCR2 domain.
Our results are generally in agreement with prior
experimental and computational data. C3d residues at the
acidic patch such as D36, E37, and E39 (Figure 5) were
suggested to be important to binding by a 2000 rosette
immunological assay study35 and a 2010 surface plasmon
resonance study,41 in addition to the AESOP analysis.19 Our
BD results support the importance of D36, E37, and E39 in
binding as well. C3d residues E117, D122, D128, and D147, a
cluster of residues not located at the acidic patch, demonstrated
minimal contributions to electrostatic steering, in contrast to a
mutagenesis study40 performed by authors of the older
crystallographic C3d:CR2 structure.65 This is in line with the
previous computational study19 and the 2000 and 2010
mutagenesis studies.35,41
C3d residues at the other acidic patch cluster (E160, D163,
and E166) demonstrated significant contributions to electro-
static steering, in line with the previous computational study,19
but are at odds with the 2000 mutagenesis study. However, the
influence of electrostatic steering of C3d residues K162 and
E167 are in contrast to the previous computational study19 and
2000 mutagenesis study.35 Here, we found that removal of
K162, which is located within the acidic patch of C3d, did not
affect the electrostatic steering of the formation of the
encounter complex as dramatically as it was suggested by the
results of the 2000 rosette study35 and the previous AESOP
study.19 It is likely that the role of K162 is to stabilize the
negative surface patch, and its removal produces local structural
rearrangements to optimize the remaining electrostatic
interactions. Such structural effects are not taken into account
by the rigid model BD and AESOP studies. We should keep in
mind that the BD and AESOP analyses introduce theoretical
perturbation to assess the importance of each mutated residue
in binding of the parent proteins, and they do not aim to model
the structures of the mutated proteins.
The importance of the SCR1 domain of CR2, which was
overlooked by the original C3d:CR2 crystallographic structure,
is further emphasized in our BD results, as evidenced by the
effects of mutagenesis and electrostatic steering by CR2
residues R13, R36, and K41. This is in line with the previous
computational study where it was established that the
contributions of the SCR1 domain to the C3d:CR2 interface
are significant.19
Pharmacological Significance. Understanding the phys-
icochemical origins of the C3d:CR2 interaction is important for
Figure 5. Molecular graphic of C3d:CR2 in open-book form and locations of residues with significant contributions to electrostatic steering. The
surfaces of C3d and CR2 are rendered translucent and colored from red to white to blue according to electrostatic potential values (calculated at 150
mM ionic strength) from −5 kT/e to 0 kT/e to 5 kT/e. Residues are displayed in ball-and-stick form with atoms colored according to atom type
(carbon in gray, oxygen in red, nitrogen in blue). Residues found to demonstrate significant contributions to electrostatic steering (falling outside the
shaded area in Figure 4A,B) in this ionic strength dependence analysis and significant contributions to electrostatic interactions (greater or less than
±2.5 kJ/mol) in a previous AESOP computational alanine scan study19 are labeled with a solid black box. Residues found to demonstrate significant
contributions to electrostatic steering in this ionic strength dependence analysis but less significant interactions (within ±2.5 kJ/mol) in the AESOP
computational alanine scan study are labeled with a dashed black box. Additional residues found to have significant contributions to electrostatic
interactions in the AESOP computational alanine scan study are labeled without a box.
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the design of biomarkers and therapeutic interventions. Recent
studies have utilized information from the C3d−CR2
interaction to design C3d-binding biomarkers for imaging of
complement activation, such as fluorescently labeled antibod-
ies,66 small fluorescent molecules,67 and CR2-bound iron
nanoparticles.68
The complement system has been a target of inhibition in
several studies, but only two anticomplement drugs are
currently in the clinic.69 Although, a lack of proper regulation
of complement response has been implicated in several
autoimmune and inflammatory diseases, inhibiting complement
activation may reduce the efficacy of response to infection and
injury. Recent studies have demonstrated in animal models
effective targeted delivery of CR2-attached protein complement
inhibitors, through the CR2:C3d interaction, to sites of local
inflammation, which are abundant of C3d-opsonized tis-
sues.70−75 Such inhibitors included fragments of the alternative
pathway regulator Factor H, or the complement inhibitory
protein Crry, but can also be low-affinity C3d-bound or CR2-
bound peptidic or nonpeptidic molecules. Therefore, the
C3d:CR2 interaction is an ideal target for therapeutic
development because it allows for inhibition of complement
response through the alternative pathway while retaining the
ability to fight infection through the lectin and classical
pathways. The C3d:CR2 interaction can also be a target for
therapeutic intervention in cases of autoimmunity because it
allows for inhibition of complement-enhanced adaptive
immune response, through the inhibition of the formation of
the B cell receptor−coreceptor complex.
■ CONCLUSION
We have investigated the role of electrostatic steering on the
C3d:CR2 interaction, using BD simulations. We demonstrate
that the predicted kon reaction rate constant depends on ionic
strength, which is possible only if electrostatics contributes
significantly to the C3d:CR2 interaction. We have also
evaluated the contributions of specific ionizable residues to
the electrostatic acceleration of the interaction through
computational mutagenesis and ionic strength dependence
analysis. We demonstrate that computational mutations of
ionizable residues previously known from experimental studies
to be significant to the C3d:CR2 interaction result in a reduced
kon rate constant. Therefore, the replaced (original) residues
contribute to the acceleration of the interaction in the native
complex. These results are in agreement with a previous
computational analysis, based on the calculation of electrostatic
free energies of association for a family of experimentally
known mutants and an alanine scan family of C3d:CR2
complexes.19 Interestingly, acidic residues within an evolutio-
narily significant “electrostatic hotspot” in C3d are the major
contributors to the complex formation. As was suggested in a
previous work, this acidic patch in the complement degradation
product C3d may have evolved to establish a link between
innate immunity (complement system) and adaptive immunity
(B cell bound antibodies).47 Although this C3d “electrostatic
hotspot” may be destabilizing local structure, it accelerates
interaction with CR2 and function. As was suggested by
Professor J. Andrew McCammon in his 2009 “Darwinian
Biophysics” article, evolution favors speed and acceleration of
function;76 and evolution favors function over stability.77
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